Cargando…

TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations

BACKGROUND: The role of telomerase reverse transcriptase (TERT) in gliomagenesis has been recently further strengthened by the frequent occurrence of TERT promoter mutations (TERTp-mut) in gliomas and evidence that the TERT SNP genetic rs2736100 influences glioma risk. TERTp-mut creates a binding si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Labussière, M, Di Stefano, A L, Gleize, V, Boisselier, B, Giry, M, Mangesius, S, Bruno, A, Paterra, R, Marie, Y, Rahimian, A, Finocchiaro, G, Houlston, R S, Hoang-Xuan, K, Idbaih, A, Delattre, J-Y, Mokhtari, K, Sanson, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229642/ https://www.ncbi.nlm.nih.gov/pubmed/25314060 http://dx.doi.org/10.1038/bjc.2014.538

Ejemplares similares

Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci
por: Labreche, Karim, et al.
Publicado: (2018)

Quantifying the heritability of glioma using genome-wide complex trait analysis
por: Kinnersley, Ben, et al.
Publicado: (2015)

IDH Mutations: Genotype-Phenotype Correlation and Prognostic Impact
por: Wang, Xiao-Wei, et al.
Publicado: (2014)

Tumor and Endothelial Cell Hybrids Participate in Glioblastoma Vasculature
por: El Hallani, Soufiane, et al.
Publicado: (2014)

Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222
por: Enciso-Mora, V, et al.
Publicado: (2013)

NOTCH2 Is Neither Rearranged nor Mutated in t(1;19) Positive Oligodendrogliomas
por: Benetkiewicz, Magdalena, et al.
Publicado: (2009)

ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
por: Bikeye, Sandra-Nadia Ngwabyt, et al.
Publicado: (2010)

Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis
por: Kinnersley, Ben, et al.
Publicado: (2016)

Correction: ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
por: Bikeye, Sandra-Nadia Ngwabyt, et al.
Publicado: (2011)

Genome-wide association study identifies multiple susceptibility loci for glioma
por: Kinnersley, Ben, et al.
Publicado: (2015)

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
por: Ducray, François, et al.
Publicado: (2008)

Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors
por: Terziev, Robert, et al.
Publicado: (2021)

A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas
por: Rosenberg, Shai, et al.
Publicado: (2018)

Prediction of Response to Temozolomide in Low‐Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics
por: Mazzocco, P, et al.
Publicado: (2015)

Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas
por: Kamoun, Aurélie, et al.
Publicado: (2016)

Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice
por: Leuraud, P, et al.
Publicado: (2003)

Human TERT promoter mutations as a prognostic biomarker in glioma
por: Powter, Branka, et al.
Publicado: (2021)

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951
por: Idbaih, Ahmed, et al.
Publicado: (2010)

TCF12 is mutated in anaplastic oligodendroglioma
por: Labreche, Karim, et al.
Publicado: (2015)

A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma
por: Catteau, Aurélie, et al.
Publicado: (2014)

IDH1(R132H) Mutation Increases U87 Glioma Cell Sensitivity to Radiation Therapy in Hypoxia
por: Wang, Xiao-Wei, et al.
Publicado: (2014)

Elevated TERT Expression in TERT-Wildtype Adult Diffuse Gliomas: Histological Evaluation with a Novel TERT-Specific Antibody
por: Masui, Kenta, et al.
Publicado: (2018)

Significance of TERT and ATRX mutations in glioma
por: Liu, Jiayu, et al.
Publicado: (2019)

An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas
por: Laffaire, Julien, et al.
Publicado: (2014)

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF(V600E)/TERT promoter double-mutated glioma
por: Gabler, Lisa, et al.
Publicado: (2019)

The expression of hTR and hTERT in human breast cancer: correlation with clinico-pathological parameters
por: Hosseini-Asl, Saied, et al.
Publicado: (2006)

Purine and pyrimidine metabolism in human gliomas: relation to chromosomal aberrations.
por: Bardot, V., et al.
Publicado: (1994)

TERT promoter mutations and monoallelic activation of TERT in cancer
por: Huang, F W, et al.
Publicado: (2015)

Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk
por: Walsh, Kyle M., et al.
Publicado: (2014)

The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas
por: Lee, Yujin, et al.
Publicado: (2017)

Is There an Independent Role of TERT and NF1 in High Grade Gliomas?
por: Razis, Evangelia, et al.
Publicado: (2019)

Leveraging Ethnic Group Incidence Variation to Investigate Genetic Susceptibility to Glioma: A Novel Candidate SNP Approach
por: Jacobs, Daniel I., et al.
Publicado: (2012)

The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
por: Vuong, Huy Gia, et al.
Publicado: (2020)

Reactivation of Tert in the medial prefrontal cortex and hippocampus rescues aggression and depression of Tert(−/−) mice
por: Zhou, Q-G, et al.
Publicado: (2016)

The TERT variant rs2736100 is associated with colorectal cancer risk
por: Kinnersley, B, et al.
Publicado: (2012)

Magnetic Resonance Spectroscopy in Diagnosis and Follow-Up of Gliomas: State-of-the-Art
por: Galijasevic, Malik, et al.
Publicado: (2022)

Mechanisms and therapeutic implications of hypermutation in gliomas
por: Touat, Mehdi, et al.
Publicado: (2020)

Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies
por: Vialatte de Pémille, Clément, et al.
Publicado: (2018)

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences
por: Heidenreich, Barbara, et al.
Publicado: (2015)

TERT rs2853676 polymorphisms correlate with glioma prognosis in Chinese population
por: He, Xue, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kg7j3ul9qpipko6q021hvv2jmd